Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025)
Equillium (EQ) posted quarterly Change in Acquisitions & Divestments of $4.5 million for Q1 2025, little changed year-over-year from $4.5 million in Q1 2024, and down 25.0% quarter-over-quarter from $6.0 million in Q4 2024.
Analysis
Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends
Equillium (EQ) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $4.5 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Change in Acquisitions & Divestments changed 0.0% year-over-year to $4.5 million; the TTM figure through Dec 2025 stood at $4.5 million (down 85.71% YoY), while the FY2025 annual figure was $4.5 million, down 85.71% from the prior year.
- Change in Acquisitions & Divestments declined to $4.5 million in Q1 2025 per EQ's latest filing, from $6.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $29.0 million in Q2 2021 and bottomed at $2.5 million in Q4 2021.
- Historically, Change in Acquisitions & Divestments has averaged $10.6 million across 5 years, with a median of $11.0 million in 2023.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments sank 79.94% — and 2023, when it surged 380.0%.
- Equillium's Change in Acquisitions & Divestments stood at $2.5 million in 2021, then soared by 179.2% to $7.0 million in 2022, then surged by 71.92% to $12.0 million in 2023, then slumped by 50.0% to $6.0 million in 2024, then retreated by 25.0% to $4.5 million in 2025.
- Business Quant data shows EQ's Change in Acquisitions & Divestments at $4.5 million in Q1 2025, $6.0 million in Q4 2024, and $12.0 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 8.75 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 16.50 Mn |
| Jun 30, 2021 | 28.99 Mn |
| Mar 31, 2021 | 12.47 Mn |
| Dec 31, 2020 | 8.19 Mn |
| Sep 30, 2020 | 5.23 Mn |
| Jun 30, 2020 | 8.46 Mn |